Full Text View
Tabular View
No Study Results Posted
Related Studies
Anti-Depressants vs Physiotherapy in Management of Fibromyalgia
This study has been completed.
First Received: June 23, 2008   Last Updated: June 25, 2008   History of Changes
Sponsors and Collaborators: Mahatma Gandhi Institute of Medical Sciences
Department of Medicine, MGIMS Sevagram
Information provided by: Mahatma Gandhi Institute of Medical Sciences
ClinicalTrials.gov Identifier: NCT00704899
  Purpose

To compare the efficacy of physiotherapy and anti-depressants in disability reduction in patients of Fibromyalgia syndrome.


Condition Intervention Phase
Fibromyalgia
Procedure: Physiotherapy
Drug: Amitryptiline
Phase III

MedlinePlus related topics: Antidepressants Fibromyalgia
Drug Information available for: Amitriptyline Amitriptyline hydrochloride Triavil
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Effect of Anti-Depressants vs Physiotherapy in Management of Fibromyalgia Syndrome: What Predicts a Clinical Benefit?

Further study details as provided by Mahatma Gandhi Institute of Medical Sciences:

Primary Outcome Measures:
  • Reduction in FIQ score from the baseline [ Time Frame: Two years ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Reduction in Tender point score [ Time Frame: Two years ] [ Designated as safety issue: No ]
  • Reduction in Brief psychiatric rating score [ Time Frame: Two Years ] [ Designated as safety issue: No ]

Enrollment: 175
Study Start Date: March 2006
Study Completion Date: April 2008
Primary Completion Date: December 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
2: Experimental
anti-depressants
Drug: Amitryptiline
Amitryptiline 25mg once daily
1: Experimental
physiotherapy
Procedure: Physiotherapy
Structured exercise regimen

Detailed Description:

Research Question:

Does the use of physiotherapy or pharmacotherapy help in improving quality of life in patients of fibromyalgia as judged by fibromyalgia impact questionnaire at a 6 month follow up period?

Study hypothesis:

Physiotherapy is no better than pharmacotherapy in improving the quality of life in patients of fibromyalgia as judged by fibromyalgia impact questionnaire. Study type- Interventional STUDY DESIGN: open label alternate patient treatment allocation Ethical approval for the trial protocol has been obtained from the institute's ethics committee of Mahatma Gandhi Institute of Medical Sciences, Sevagram. Subjects and Methods The study will be conducted in Kasturba Hospital and Mahatma Gandhi Institute of Medical Sciences, Sevagram, from 1 march 2006 - 1 dec 2007. Patients will be selected to enter the study, in such a way that every patient presenting with chronic muscular pain will be screened in the study and patients fulfilling inclusion criteria will be recruited in the study.

Study population:

Total of 175 patients will be included in the study.

Methods:

The investigators will screen all patients who are referred to them for inclusion in the study. Written informed consent will be obtained from all participants. The patients included in the study will be administered a standardized questionnaire to record socio-demographic characteristics, symptom characteristics and history of previous visits to a health care provider. The socio-economic score (SES) will be determined using a validated questionnaire.[6] Briefly, the questionnaire consists of following: (1) household profile, (2) material possession profile, (3) educational profile, (4) occupational profile, (5) economic profile (6) possessed land or house cost profile and (7) social profile. Fibromyalgia impact questionnaire (FIQ) will be used to determine a baseline score. [7] For the purpose of the study this questionnaire is translated to local language (Marathi), and back-translated to English to ensure its accuracy. Minor modifications have been done in the questionnaire to make it suitable for our setting (for example: the use of washer or dryer for laundry was modified to washing the laundry by themselves). Assessment of psychiatric co morbidity will be done using the Brief Psychiatric Rating Scale (BPRS), which is an 18 item instrument, each item has a seven severity grades.[8] A score of 32 or more indicates presence of psychopathology.[9]

Interventions:

A trained Physiotherapist will conduct a uniform structured physical training and aerobic session for one group of patients. The patients will be advised to perform the exercises daily twice for at least 10 minutes. There will be a step up pattern of exercise regimen followed with relaxation, stretching and strengthening techniques. The methodology is described in box 1. The second group of patients will receive antidepressant in the form open label amitriptyline 25 mg once daily at bedtime. The dose of the drug may be increased if required. All patients will be also offered pharmacologic treatment with 50 mg tramadol in thrice daily doses and as required. The treatment recommendations are based on standard recommendations on the management of fibromyalgia.[5]

Outcome assessment All patients will be followed up for six months at monthly intervals. At each visit the study investigators will determine the course of the disease and compliance with therapy. The FIQ score will be assessed at the end of 6 monthly visits. Reduction in FIQ score from the baseline will be used as the principle outcome measure.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient's between 18-60 yrs, belonging to either sex. With symptoms of chronic muscular pain of at least 12 weeks (that may or may not be consecutive) who fulfill the American College of Rheumatology (ACR) criteria for the diagnosis of Fibromyalgia

Exclusion Criteria:

  • Patients of age group more than 60 yrs and below 18 years
  • Pregnant or lactating females.
  • Patients with a history of trauma.
  • Patients with severe co morbid illness which prevents physical activity (for example, cardiovascular problems)
  • Patients with the presence of specific medical disorders which require immediate treatment (for example, fractures, infectious diseases),
  • Patients with associated neurological abnormality
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00704899

Locations
India, Maharashtra
Mahatma Gandhi Institute of Medical Sciences
Sevagram, Maharashtra, India, 442102
Sponsors and Collaborators
Mahatma Gandhi Institute of Medical Sciences
Department of Medicine, MGIMS Sevagram
  More Information

No publications provided

Responsible Party: Department of Medicine, MGIMS Sevagram ( Prof AP Jain )
Study ID Numbers: MGIMS-001
Study First Received: June 23, 2008
Last Updated: June 25, 2008
ClinicalTrials.gov Identifier: NCT00704899     History of Changes
Health Authority: India: Indian Council of Medical Research

Study placed in the following topic categories:
Neurotransmitter Agents
Adrenergic Agents
Fibromyalgia
Myofascial Pain Syndromes
Psychotropic Drugs
Pain
Rheumatic Diseases
Antidepressive Agents, Tricyclic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Analgesics, Non-Narcotic
Amitriptyline
Peripheral Nervous System Agents
Analgesics
Antidepressive Agents

Additional relevant MeSH terms:
Neurotransmitter Uptake Inhibitors
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Adrenergic Uptake Inhibitors
Fibromyalgia
Myofascial Pain Syndromes
Physiological Effects of Drugs
Nervous System Diseases
Psychotropic Drugs
Rheumatic Diseases
Pharmacologic Actions
Antidepressive Agents, Tricyclic
Muscular Diseases
Musculoskeletal Diseases
Neuromuscular Diseases
Sensory System Agents
Analgesics, Non-Narcotic
Therapeutic Uses
Amitriptyline
Peripheral Nervous System Agents
Analgesics
Central Nervous System Agents
Antidepressive Agents

ClinicalTrials.gov processed this record on May 06, 2009